ASHLEY PRESLEY: Open Payments
NPI 1841661865 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,047 in 50 payments from 17 companies in 2025. Trend: 2023 $768 · 2024 $1,326 · 2025 $1,047
Food & beverage: $967Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $192 |
| ABBVIE INC. | 10 | $160 |
| Novartis Pharmaceuticals Corporation | 7 | $117 |
| Merck Sharp & Dohme LLC | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| Celgene Corporation | 3 | $76 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| PFIZER INC. | 2 | $45 |
| SOBI, INC | 2 | $39 |
| BeOne Medicines USA, Inc. | 1 | $34 |
Products named: EPKINLY, ERLEADA, KEYTRUDA, IMFINZI, KISQALI, REBLOZYL, OPDIVO, Vonjo.
Industry payments across AL — which companies pay providers there.
